Atlas Trials

Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

Clinical trial NCT07539753 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07539753
Sponsor
Nanfang Hospital, Southern Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerBrain MetastasesHR+/HER2- Breast Cancer
Start date
2026-06-01
Primary completion
2029-08-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.